Contract drug research in China is expanding

03/24/2013 | PharmaTimes (U.K.)

Contract research for the pharmaceutical industry in China reached $3.5 billion to $4.5 billion two years ago, according to a new report from Research and Markets. China should continue to grow as a market for contract research organizations as multinational firms look for venues with low costs, a skilled professional pool and a broad range of critical diseases and conditions to study.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ